Cointime

Pathwork Diagnostics

company

About

Pathwork Diagnostics develops and delivers molecular diagnostic solutions for oncology.

  • 11 - 50

Highlights

Total Funding Amount
$11M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$11M
Industries
Biotechnology,Genetics,Health Care,Health Diagnostics
Founded date
Jan 1, 2002
Number Of Employee
11 - 50
Operating Status
Active

Pathwork Diagnostics is based in Redwood City, California. The company develops and delivers innovative molecular diagnostics for oncology. The Pathwork Tissue of Origin Test for frozen tissue was the first to receive FDA clearance for a microarray-based gene expression test that aids in identifying challenging tumors, including poorly differentiated, undifferentiated, and metastic cancer.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$11M
Pathwork Diagnostics has raised a total of $11M in funding over 2 rounds. Their latest funding was raised on Jul 6, 2006 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 6, 2006 Series Unknown $11M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Pathwork Diagnostics is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures — Series Unknown
Cointime
เนื้อหา
บริษัท